CALAF ALSINA, JOAQUIM UAB
jcalaf@santpau.cat
Estadella Tarriel, Josep Ramon FGS
Guinot Gasull, Misericordia FGS
Mayordomo Bofill, Isabet
Miarons Ferre, Bruna FGS
Perello Capo, Josep FGS
CALAF ALSINA, JOAQUIM UAB
jcalaf@santpau.cat
Estadella Tarriel, Josep Ramon FGS
Guinot Gasull, Misericordia FGS
Mayordomo Bofill, Isabet
Miarons Ferre, Bruna FGS
Perello Capo, Josep FGS
(JIF 2022)
-Calaf J, Cano A, Guañabens N, Palacios S, Cancelo MJ, Castelo C, Larrainzar R, Neyro JL, Nogues X, Diez A. Sequential management of postmenopausal health and osteoporosis: An update. MATURITAS. 2023; 177:107846. DOI:10.1016/j.maturitas.2023.107846. PMID:37738717. IF:4,900 (Q1/2D). Document type: Review.
-Estadella J, Perelló J, Muñoz R. Update on the possibilities of hormonal medical treatment for heavy menstrual bleeding. Clinica E Investigacion En Ginecologia Y Obstetricia. 2023; 50(1):100819. DOI:10.1016/j.gine.2022.100819. Document type: Review.
-Perelló J, Estadella J, Gich I, Bailón M, Llurba E, Calaf J. Bleeding profile and safety of a levonorgestrel 13.5 mg intrauterine device versus Nova T copper 380 mm(2) intrauterine device: Results of a 3-year, single-center, randomized phase 4 study. CONTRACEPTION. 2023; 127:110127. DOI:10.1016/j.contraception.2023.110127. PMID:37487868. IF:2,900 (Q2/5D). Document type: Article.
-Perelló J, Quílez JC, Gutiérrez J, Lobo P, Parra I, Cristóbal I, Andeyro M, Herrero M, Rius J, Calaf J. Use of Contraceptive Methods Among Women in the General Population and Female Gynecologists in Spain: the ELEGIAN Survey. WOMENS HEALTH REPORTS. 2023; 4(1)DOI:10.1089/whr.2023.0048. PMID:37818182. Document type: Article.
-Perelló J, Quílez JC, Lobo P, Andeyro M, Cristóbal I, Gutiérrez J, Herrero M, Parra I, Estadella J, Rius J, Calaf J. Prevalence and impact of heavy menstrual bleeding in Spain: Results of a national survey. Clinica E Investigacion En Ginecologia Y Obstetricia. 2023; 50(3):100877. DOI:10.1016/j.gine.2023.100877. Document type: Article.
-Perello J, Rius J, Andeyro M, Calaf J. Sensitivity to Change of the SAMANTA Questionnaire, a Heavy Menstrual Bleeding Diagnostic Tool, After 1 Year of Hormonal Treatment. JOURNAL OF WOMENS HEALTH. 2023; 32(2)DOI:10.1089/jwh.2022.0155. PMID:36576860. IF:3,500 (Q1/2D). Document type: Article.
-Quílez JC, Perelló J, Parra I, Andeyro M, Cristóbal I, Gutiérrez J, Herrero M, Lobo P, Rius J. Desarrollo de una herramienta de evaluación objetiva de la habilidad técnica en la inserción de dispositivos intrauterinos liberadores de levonorgestrel con sistema de inserción Evoinserter®. Progresos De Obstetricia Y Ginecologia. 2023; 66(3) Document type: Article.
-Sanger N, Menabrito M, Sardo AD, Estadella J, Verguts J. Fertility preservation counselling for women with endometriosis: a European online survey. ARCHIVES OF GYNECOLOGY AND OBSTETRICS. 2023; 307(1)DOI:10.1007/s00404-022-06616-y. PMID:35829767. IF:2,600 (Q3/6D). Document type: Article.
-Silva AL, Catherino WH, Estrade JP, Koga K, Singh SS, Vannuccini S, Yang X, Lahav A, Caetano C, Calaf J. The HOPE study: evaluating the impact of an online educational resource for heavy menstrual bleeding on the patient-physician dynamic. WOMEN & HEALTH. 2023; 63(5)DOI:10.1080/03630242.2023.2220806. PMID:37291687. IF:1,600 (Q2/5D). Document type: Article.
-von S, Bauerfeind A, Becker K, Franke C, Fruzzetti F, Calaf J, Keck C, Heinemann K. NOMAC-E2 shows a better contraceptive effectiveness than LNG combined oral contraceptives in women under 25: real-world PRO-E2 study. GYNECOLOGICAL ENDOCRINOLOGY. 2023; 39(1):2162036. DOI:10.1080/09513590.2022.2162036. PMID:36617423. IF:2,000 (Q3/8D). Document type: Article.
(JIF 2022)
